CBD Side Effects: What You Need to Know Before Taking CBD

CBD’s reputation as a natural, safe wellness supplement is largely deserved, but “safe” does not mean “without any effects on the body,” and the growing popularity of CBD has outpaced many consumers’ understanding of its potential downsides. Every biologically active compound that can produce therapeutic effects is also capable of producing unwanted effects, and CBD is no exception. The World Health Organization concluded in its 2018 comprehensive review that CBD has a favorable safety profile with no evidence of recreational misuse potential, but the same report documented a range of adverse effects observed in clinical settings, effects that every CBD user should understand before starting supplementation.

The context surrounding CBD side effects matters enormously. The vast majority of serious adverse events in the clinical literature occurred at pharmaceutical-grade doses (300mg to 1,500mg per day) administered under medical supervision for conditions like epilepsy, while most consumer-market CBD users take 10 to 75mg per day. The side effect profile at typical consumer doses is considerably milder than what appears in high-dose clinical trials. However, drug interactions, CBD’s ability to alter the metabolism of other medications, represent a genuinely serious safety consideration that applies regardless of dose, and this topic receives far less attention than it deserves in consumer marketing.

This guide examines every documented CBD side effect with references to the clinical evidence, explains the mechanism behind each effect, identifies who is most at risk, and provides practical strategies for minimizing unwanted effects while maintaining the therapeutic benefits.

Common CBD Side Effects

Drowsiness and Fatigue

Drowsiness is the most frequently reported CBD side effect and was documented as the leading adverse event in the landmark 2019 Permanente Journal study, where 10% of the 72 participants reported fatigue as a notable side effect. The relationship between CBD and sleepiness is dose-dependent and somewhat paradoxical: at lower doses (below approximately 15mg), some research suggests CBD has a mildly alerting effect, while at higher doses (above 50mg), sedating effects become more pronounced. This biphasic pattern is consistent with CBD’s interaction with multiple receptor systems, at lower doses, its interaction with serotonin 5-HT1A receptors and adenosine reuptake inhibition may produce mild stimulation, while at higher doses, its GABAergic effects and potential hypothalamic actions promote relaxation and sleepiness.

For users who experience unwanted drowsiness, the most effective strategy is dose reduction. Taking a lower dose or splitting a larger daily dose into two smaller administrations can maintain therapeutic benefits while reducing sedation. Timing also matters: if daytime drowsiness is a problem, shifting your dose to the evening allows the sedating effect to support sleep rather than impair daytime function. If you are using CBD specifically for insomnia, the drowsiness is not a side effect but the intended mechanism, though excessively high doses that produce next-day grogginess suggest the dose should be reduced slightly.

Dry Mouth

Dry mouth (xerostomia) is a commonly reported CBD side effect that results from CBD’s interaction with cannabinoid receptors in the salivary glands. A 2006 study published in Experimental Biology and Medicine identified CB1 and CB2 receptors in the submandibular salivary glands of rats, and demonstrated that cannabinoid receptor activation reduces saliva production. While dry mouth from CBD is typically mild and transient, far less severe than the dry mouth caused by anticholinergic medications, it can be uncomfortable, particularly for users who already experience dry mouth due to other medications or medical conditions.

The practical management of CBD-related dry mouth is straightforward: stay well-hydrated before and after taking CBD, keep water nearby, and consider sugar-free lozenges or gum to stimulate saliva production. Sublingual administration (holding CBD oil under the tongue) may produce more noticeable dry mouth than swallowed capsules or gummies because the CBD is in direct contact with oral tissues. Switching to an oral format or reducing the sublingual hold time can help if dry mouth is bothersome.

Gastrointestinal Effects

Diarrhea and changes in appetite are among the most consistently reported CBD side effects in clinical trials. In the clinical trials for Epidiolex (the FDA-approved CBD medication for epilepsy), diarrhea occurred in approximately 9% to 20% of participants, making it one of the most common adverse events at pharmaceutical doses. At consumer-level doses, gastrointestinal effects are less common and usually milder, but they still occur in a meaningful percentage of users, particularly during the initial days of use or after dose increases.

The mechanism behind CBD-related gastrointestinal effects likely involves multiple pathways. The endocannabinoid system is heavily represented in the gastrointestinal tract, where CB1 and CB2 receptors regulate motility, secretion, and inflammation. CBD’s modulation of these receptors can alter bowel function in some individuals. Additionally, the carrier oil in CBD products (typically MCT oil from coconut) can itself cause digestive upset in sensitive individuals, particularly at larger volumes. If you experience diarrhea after starting CBD, it is worth determining whether the CBD or the carrier oil is the culprit by trying a different product format (such as capsules or gummies instead of oil) before attributing the effect to CBD itself.

Changes in Appetite and Weight

Unlike THC, which is well-known for stimulating appetite (the “munchies”), CBD’s effects on appetite are more variable and less predictable. Some clinical trial participants report decreased appetite, while others report increased appetite. In the 2019 Permanente Journal study, appetite changes were noted in some participants but were not consistent in direction. The variability likely reflects CBD’s complex pharmacology, it does not directly activate CB1 receptors (the primary driver of THC-induced appetite stimulation) but modulates endocannabinoid tone in ways that may increase or decrease appetite depending on an individual’s baseline state. For most consumer-level users, appetite changes are subtle and not clinically significant.

CBD Drug Interactions: The Most Important Safety Consideration

The Cytochrome P450 Mechanism

While the common side effects of CBD are relatively mild and manageable, drug interactions represent the most clinically significant safety risk associated with CBD use, and paradoxically, this topic receives the least attention in consumer marketing. CBD is a potent inhibitor of the cytochrome P450 (CYP450) enzyme system in the liver, particularly the CYP3A4 and CYP2C19 isoforms. These enzymes are responsible for metabolizing approximately 60% of all clinically used medications. When CBD inhibits these enzymes, medications that depend on them for breakdown accumulate in the bloodstream at higher-than-intended concentrations, effectively amplifying both the therapeutic effects and the side effects of those medications.

The most frequently cited proxy for CBD drug interaction risk is the “grapefruit test”, if a medication carries a warning to avoid grapefruit or grapefruit juice, it is metabolized by the same CYP450 enzymes that CBD inhibits, and an interaction is likely. This is because grapefruit contains furanocoumarins that inhibit CYP3A4 through a mechanism similar to CBD’s. However, the grapefruit test is a rough heuristic, not an exhaustive indicator, some medications interact with CBD through CYP2C19 inhibition rather than CYP3A4, and the grapefruit warning only covers the latter. The safest approach is to consult a pharmacist or physician about any specific medication before combining it with CBD.

High-Risk Medication Categories

Several medication categories warrant particular caution when combined with CBD. Blood thinners, especially warfarin, have the most well-documented interaction: a case report published in the journal Epilepsy & Behavior Case Reports documented a patient whose INR (a measure of blood clotting time) increased significantly after starting CBD, requiring a warfarin dose reduction. Since elevated INR increases the risk of dangerous bleeding, any warfarin user considering CBD must involve their prescribing physician and undergo more frequent INR monitoring.

Anti-seizure medications (clobazam, valproate, topiramate) interact with CBD in complex ways that were extensively documented during the Epidiolex clinical trials. CBD significantly increases clobazam blood levels through CYP2C19 inhibition, which can result in excessive sedation. CBD combined with valproate may increase the risk of liver enzyme elevations, which is why liver function monitoring is required for patients taking Epidiolex with valproate. Other high-caution categories include immunosuppressants (tacrolimus, cyclosporine), certain heart medications (calcium channel blockers, beta-blockers metabolized by CYP3A4), benzodiazepines, antidepressants (SSRIs and SNRIs), opioid pain medications, and statin cholesterol drugs. In each case, CBD’s enzyme inhibition can increase the medication’s blood level beyond the therapeutic range.

The practical difficulty of managing CBD-drug interactions is that the degree of interaction depends on the CBD dose, the specific medication, the medication dose, and the individual’s own CYP450 enzyme activity, which is influenced by genetics, age, liver health, and other concurrent medications. A person taking 15mg of CBD daily may have a clinically negligible interaction with the same medication that produces a significant interaction at 100mg of CBD daily. This is why blanket statements like “CBD interacts with everything” are as unhelpful as dismissive statements like “it’s just a supplement.” The interaction risk exists on a spectrum, and the only way to assess it for your specific situation is to consult a pharmacist who can evaluate the specific medications you take, the doses you take them at, and the CBD dose you plan to use.

Less Common Side Effects

Liver Enzyme Elevations

Elevations in liver enzymes (particularly ALT and AST) were observed during the Epidiolex clinical trials and represent a dose-dependent CBD side effect that warrants discussion, particularly for users taking high doses or combining CBD with other hepatotoxic medications. The FDA’s prescribing information for Epidiolex notes that liver enzyme elevations occurred in approximately 13% of patients receiving CBD at doses of 20mg/kg/day, doses vastly higher than typical consumer use. The risk was significantly increased in patients concomitantly taking valproate. At standard consumer doses (10 to 75mg total per day), clinically significant liver enzyme elevations are very unlikely in healthy individuals, but users with pre-existing liver disease or those taking hepatotoxic medications should exercise caution and consider periodic liver function testing.

Blood Pressure Changes

CBD may cause a transient and modest decrease in blood pressure, which can manifest as lightheadedness or dizziness, particularly when standing up quickly (orthostatic hypotension). A 2017 study in JCI Insight found that a single 600mg dose of CBD reduced resting systolic blood pressure by 6 mmHg in healthy volunteers, a statistically significant but clinically modest reduction. At typical consumer doses, this effect is generally imperceptible, but individuals who already have low blood pressure or who take antihypertensive medications should be aware of the potential for additive blood pressure reduction.

Who Should Avoid CBD or Use It with Extra Caution

Populations Requiring Special Consideration

While CBD is safe for most healthy adults at typical consumer doses, several populations should either avoid CBD entirely or use it only under direct medical supervision. Pregnant and breastfeeding women are advised by the FDA to avoid all CBD products, as there is insufficient safety data for fetal and infant exposure. Individuals with liver disease should consult their hepatologist before using CBD due to the potential for liver enzyme elevations. People taking multiple prescription medications, particularly those in the high-risk categories described above, should consult a pharmacist for a comprehensive drug interaction review before adding CBD to their regimen.

Children and adolescents should not use over-the-counter CBD products without medical oversight, even though the FDA has approved Epidiolex (a pharmaceutical-grade CBD formulation) for pediatric epilepsy. The safety of unregulated, consumer-market CBD products in children has not been established, and dosing, purity, and consistency concerns are amplified when the user is a child. Similarly, elderly individuals who are typically on multiple medications and may have reduced liver function should approach CBD with caution and start at the lowest possible dose.

Individuals with a history of substance abuse disorders should discuss CBD use with their treatment provider. While the WHO has stated that CBD does not exhibit effects indicative of abuse or dependence potential, and it is pharmacologically distinct from THC, some treatment programs advise against any cannabis-derived products as a matter of relapse prevention policy. People who will undergo surgery should also be aware that CBD’s effects on blood pressure and its interactions with anesthetic agents may prompt an anesthesiologist to recommend discontinuation 1-2 weeks before a scheduled procedure, always disclose CBD use during pre-operative consultations.

Conclusion

The side effect profile of CBD is genuinely mild compared to most pharmaceutical alternatives for the conditions it is commonly used to address, the drowsiness, dry mouth, and gastrointestinal effects that represent the most common CBD side effects are typically manageable and dose-dependent. However, the clinical significance of CBD’s drug interactions through CYP450 enzyme inhibition cannot be understated, and every CBD user who takes prescription medications should discuss potential interactions with their healthcare provider before starting supplementation.

The key to minimizing side effects is the same principle that governs effective CBD dosing: start low, go slow, and pay attention to your body. Most adverse effects emerge at higher doses and resolve with dose reduction. Keeping a simple daily log of your dose, timing, and any symptoms makes it easier to identify cause-and-effect relationships and adjust your regimen accordingly. Product quality also plays an underappreciated role in side effects, contaminants like heavy metals, pesticides, residual solvents, and undisclosed THC in low-quality products can produce adverse effects that are mistakenly attributed to CBD itself. Choosing products from manufacturers who provide batch-specific, third-party Certificates of Analysis from ISO 17025-accredited laboratories eliminates this variable and ensures that any effects you experience are genuinely from CBD rather than from manufacturing deficiencies.

It is also worth placing CBD’s side effect profile in comparative context. The medications most commonly prescribed for the same conditions CBD is used for, benzodiazepines for anxiety, opioids for pain, sleep medications like zolpidem for insomnia, carry dramatically more serious side effect profiles including physical dependence, withdrawal syndromes, cognitive impairment, respiratory depression, and overdose risk. This does not mean CBD should replace prescription medications without medical guidance, but it does provide perspective: when managed properly, the risk-benefit ratio of CBD compares favorably for many users.

The Bottom Line: CBD is one of the safest supplements available for the conditions it addresses, but safety requires informed use, understand the side effects, respect the drug interactions, start at a low dose, and always disclose CBD use to your healthcare providers.